COX inhibitor Amfenac sodium monohydrate, Purity ≥98%

Synonym: 61618-27-7; Sodium 2-(2-amino-3-benzoylphenyl)acetate hydrate; Amfenac sodium hydrate; Amfenac sodium monohydrate; Amfenac sodium H₂O; Amfenac sodium salt monohydrate; COX inhibitor

MDL: MFCD00941383
CAS Number: 61618-27-7
Compound CID: 23663941

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Amfenac sodium monohydrate, soluble in DMSO, water and ethanol, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.

Molecular Weight

295.27

Molecular Formula

C₁₅H₁₂NO₃.H₂O.Na

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 50 mg/mL (169.33 mM); Water: 50 mg/mL (169.33 mM); Ethanol: 3 mg/mL (10.16 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Amfenac sodium monohydrate is investigated for its anti-inflammatory and analgesic properties, particularly in the treatment of ocular inflammation.

Storage

Store at -20ºC.